NCT03267446 is a NA clinical trial of 3D Doppler Ultrasound in Antepartum Hemorrhage, sponsored by Cairo University.

Who is sponsoring NCT03267446?

NCT03267446 is sponsored by Cairo University.

What drugs are being tested in NCT03267446?

Interventions in NCT03267446: 3D Doppler Ultrasound.

What condition does NCT03267446 study?

NCT03267446 studies Antepartum Hemorrhage.

Is NCT03267446 still recruiting?

NCT03267446 is currently status unknown. Last updated 30 August 2017.

Last reviewed 2017-08-30 · How we verify

NCT03267446

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Doppler Imaging and Morbidly Adherent Placenta

Status unknown NA Last updated 30 August 2017

What this trial tests

NA trial testing 3D Doppler Ultrasound in Antepartum Hemorrhage in 60 participants. Status unknown.

Timeline

29 August 2017

Primary endpoint
1 September 2018

1 September 2018

Quick facts

Lead sponsor	Cairo University
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	diagnostic
Enrollment	60
Start date	29 August 2017
Primary completion	1 September 2018
Estimated completion	1 September 2018
Sites	1 location across Egypt

Drugs / interventions tested

3D Doppler Ultrasound

Conditions studied

Antepartum Hemorrhage — all drugs for Antepartum Hemorrhage →

Sponsor

Cairo University

Who can join

Adults 18 to 45, female only, with Antepartum Hemorrhage. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to assess the value of adding 3D power Doppler (as a diagnostic technique) to gray scale technique in the antenatal diagnosis of morbidly adherent placenta as well as predict the surgical outcome regarding the type of surgery and the intra operative morbidities.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Cairo University trials

Trials by the same sponsor.

NCT04155528 — Effect of Music Therapy on Postoperative Health Outcomes · NA · not yet recruiting
NCT07363239 — CBCT-Based Safety Distance for Implant Placement Near the Inferior Alveolar Canal · not yet recruiting
NCT07374575 — Egyptian Dental Professionals' Perspectives on the Oral Microbiome and Exosomes · not yet recruiting
NCT07381153 — In-Vitro Cytotoxicity Assessment of INOX (Nanoksa G Plus) Polymer Discs · not yet recruiting
NCT07375394 — 3D-Printed Extraoral Camera for Standardized Dental Photography · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03267446 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Cairo University
Last refreshed: 30 August 2017

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03267446.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing